Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Prepaid Assets (2017 - 2025)

Cue Biopharma (CUE) has disclosed Prepaid Assets for 9 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 62.61% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 62.61% year-over-year, with the annual reading at $1.3 million for FY2025, 62.61% up from the prior year.
  • Prepaid Assets hit $1.3 million in Q4 2025 for Cue Biopharma, down from $3.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $3.1 million in Q3 2025 to a low of $160000.0 in Q2 2021.
  • Historically, Prepaid Assets has averaged $1.7 million across 5 years, with a median of $1.9 million in 2021.
  • Biggest five-year swings in Prepaid Assets: surged 1238.75% in 2022 and later crashed 32.31% in 2023.
  • Year by year, Prepaid Assets stood at $954792.0 in 2021, then dropped by 11.92% to $841000.0 in 2022, then increased by 13.56% to $955000.0 in 2023, then decreased by 15.71% to $805000.0 in 2024, then soared by 62.61% to $1.3 million in 2025.
  • Business Quant data shows Prepaid Assets for CUE at $1.3 million in Q4 2025, $3.1 million in Q3 2025, and $2.4 million in Q2 2025.